Showing results (21-30 of 179) with videos related to
Sort By:
Pageof 18
Circulation|September 6, 2022
Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority StudyJonas Oldgren, Signild Åsberg, Ziad Hijazi, et al.Upsala Journal of Medical Sciences|September 29, 2018
Atrial fibrillation in patients undergoing coronary artery surgery is associated with adverse outcomeGorav Batra, Anders Ahlsson, Bertil Lindahl, et al.International Journal of Cardiology|July 31, 2007
Risk prediction in chest pain patients by biochemical markers including estimates of renal functionKai M Eggers, Mikael Dellborg, Jonas Oldgren, et al.American Heart Journal|July 2, 2005
An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery diseaseStefan K James, Jonas Oldgren, Johan Lindbäck, et al.American Heart Journal|September 2, 2008
Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndromeKai M Eggers, Bo Lagerqvist, Jonas Oldgren, et al.Circulation|September 27, 2017
Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort StudyJohan Sundström, Jakob Hedberg, Marcus Thuresson, et al.European Heart Journal. Imaging Methods and Practice|January 29, 2026
Long-term prognostic impact of one-year change in left ventricular function after a myocardial infarction: insights from the REBUS cohortJoel Lenell, Christina Christersson, Bertil Lindahl, et al.Heart (British Cardiac Society)|March 2, 2016
All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcomeGorav Batra, Bodil Svennblad, Claes Held, et al.European Heart Journal. Cardiovascular Pharmacotherapy|April 27, 2026
Implementation of novel antithrombotic treatment strategies and outcome improvements in patients with myocardial infarction and atrial fibrillation over 20 years: a nationwide cohort studyChristian Losciale, Lars Lindhagen, Lars Wallentin, et al.Journal of the American Heart Association|March 22, 2017
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial InfarctionGorav Batra, Lars Lindhagen, Pontus Andell, et al.Pageof 18